Selected research publications
A broader lens on tuberculosis cost-effectiveness analysis: How patient-incurred costs and post-tuberculosis outcomes reshape estimates in a multi-country study – Journal: PLOS Global Public Health – Published: 11th September 2025
Acute breathlessness as a cause of hospitalisation in Malawi: A prospective, patient-centred study to evaluate causes and outcomes – Journal: Thorax – Published: 10th September 2025
The burden of multimorbidity-associated acute hospital admissions in Malawi and Tanzania a prospective multicentre cohort study – Journal: The Lancet Global Health – Published: 25th July 2025
Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial. – Journal: The Lancet Respiratory Medicine – Published: 1st December 2024
Rethinking tuberculosis morbidity quantification: a systematic review and critical appraisal of TB disability weights in cost-effectiveness analyses – Journal: PharmacoEconomics – Published: 7th August 2024
View more publications